Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Myelogenous Leukemia (CML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)Study completedNCT00709592
What this trial is testing

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Who this might be right for
Non-Hodgkin's LymphomaLeukemiaMultiple Myeloma+5 more
Virginia Commonwealth University 42
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)Ended earlyNCT01827930
What this trial is testing

Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Institut Bergonié 68
Testing effectiveness (Phase 2)WithdrawnNCT01011998
What this trial is testing

Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
New Mexico Cancer Research Alliance
Not applicableStudy completedNCT05734053
What this trial is testing

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 222
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Not applicableUnknownNCT05605379
What this trial is testing

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

Who this might be right for
Chronic Myeloid Leukemia
University Hospital, Bordeaux 88
Testing effectiveness (Phase 2)Ended earlyNCT02200380
What this trial is testing

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Who this might be right for
For DonorsRelated Donors Giving Peripheral Blood Stem Cells (PBSC) to a SiblingFor Recipients+7 more
Celldex Therapeutics 36
Not applicableUnknownNCT02338479
What this trial is testing

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia/LymphomaMyelodysplasiaAcute Myelogenous Leukemia+2 more
Center for International Blood and Marrow Transplant Research 340
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT00098033
What this trial is testing

Investigation of Clofarabine in Acute Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia
University of Texas 64
Not applicableStudy completedNCT03421626
What this trial is testing

Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)

Who this might be right for
Leukemia, Myelogenous, Chronic
Cepheid 266
Testing effectiveness (Phase 2)Study completedNCT00511303
What this trial is testing

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
University of Bologna 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04160546
What this trial is testing

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Fundacion CRIS de Investigación para Vencer el Cáncer 80
Not applicableLooking for participantsNCT06297161
What this trial is testing

Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

Who this might be right for
Chronic Leukemia Myelogenous
Pfizer 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626024
What this trial is testing

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-Positive, in RemissionChronic Myeloid Leukemia in Remission
Baylor College of Medicine 17
Next Page